These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparing measurements of biomarkers with other measurements of exposure. Saracci R IARC Sci Publ; 1997; (142):303-12. PubMed ID: 9354929 [TBL] [Abstract][Full Text] [Related]
3. Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology. Wild CP; Pisani P IARC Sci Publ; 1997; (142):143-58. PubMed ID: 9354917 [TBL] [Abstract][Full Text] [Related]
4. Exposure assessment at the workplace: implications of biological variability. Manini P; De Palma G; Mutti A Toxicol Lett; 2007 Feb; 168(3):210-8. PubMed ID: 17157456 [TBL] [Abstract][Full Text] [Related]
5. Human biomonitoring: state of the art. Angerer J; Ewers U; Wilhelm M Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741 [TBL] [Abstract][Full Text] [Related]
6. Better perspectives on use of biological markers in monitoring of lung cancer risk in occupational settings. Jedrychowski W; Maugeri U; Bianchi I G Ital Med Lav; 1993; 15(5-6):99-104. PubMed ID: 7615181 [TBL] [Abstract][Full Text] [Related]
10. [Oncoproteins and anti-oncoproteins in blood serum as biomarkers of early health effects induced by occupational and environmental carcinogens]. Lutz W; Krajewska B Med Pr; 1996; 47(5):511-8. PubMed ID: 9026631 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers in terrestrial invertebrates for ecotoxicological soil risk assessment. Kammenga JE; Dallinger R; Donker MH; Köhler HR; Simonsen V; Triebskorn R; Weeks JM Rev Environ Contam Toxicol; 2000; 164():93-147. PubMed ID: 12587835 [TBL] [Abstract][Full Text] [Related]
12. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies]. Pavanello S; Clonfero E G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438 [TBL] [Abstract][Full Text] [Related]
13. Environmental and occupational toxicants. de Vocht F; Vlaanderen J; Povey AC; Balbo S; Vermeulen R IARC Sci Publ; 2011; (163):163-74. PubMed ID: 22997861 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic insights from biomarker studies: somatic mutations and rodent/human comparisons following exposure to a potential carcinogen. Albertini RJ IARC Sci Publ; 2004; (157):153-77. PubMed ID: 15055295 [TBL] [Abstract][Full Text] [Related]
16. Environmental and chemical carcinogenesis. Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140 [TBL] [Abstract][Full Text] [Related]
17. [Biomarkers of gentotoxic risk and metabolic polymorphism]. Pavanello S; Clonfero E Med Lav; 2000; 91(5):431-69. PubMed ID: 11189784 [TBL] [Abstract][Full Text] [Related]
18. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts. Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146 [TBL] [Abstract][Full Text] [Related]
19. Carcinogen-DNA adducts as a biomarker for cancer risk. Rundle A Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556 [TBL] [Abstract][Full Text] [Related]
20. Design options for molecular epidemiology research within cohort studies. Rundle AG; Vineis P; Ahsan H Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1899-907. PubMed ID: 16103435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]